Differential regulation of hepatic organic cation transporter 1, organic anion-transporting polypeptide 1a4, bile-salt export pump, and multidrug resistance-associated protein 2 transporter expression in lymphocyte-deficient mice associates with interleukin-6 production

Journal of Pharmacology and Experimental Therapeutics

Volumn 347, Issue 1, 2013, Pages 136-144

  Bodeman, Connor E ^a   Dzierlenga, Anika L ^c   Tally, Catherine M ^a   Mulligan, Ryan M ^a   Lake, April D ^c   Cherrington, Nathan J ^c   McKarns, Susan C ^a,b  

^a Center for Cellular and Molecular Immunology   (United States)

^b University of Missouri   (United States)

^c UNIVERSITY OF ARIZONA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANALICULAR BILE SALT EXPORT PUMP PROTEIN; CARRIER PROTEINS AND BINDING PROTEINS; GAMMA INTERFERON; HEPATIC ORGANIC CATION TRANSPORTER 1; INTERLEUKIN 17; INTERLEUKIN 17F; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MESSENGER RNA; MULTIDRUG RESISTANCE PROTEIN 2; MULTIDRUG RESISTANCE PROTEIN 3; ORGANIC ANION TRANSPORTING POLYPEPTIDE 1A1; ORGANIC ANION TRANSPORTING POLYPEPTIDE 1A4; ORGANIC ANION TRANSPORTING POLYPEPTIDE 1B2; ORGANIC CATION TRANSPORTER 1; SODIUM CHLORIDE; SODIUM TAUROCHOLATE COTRANSPORTING POLYPEPTIDE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE PRODUCTION; GENE AMPLIFICATION; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TRANSPORT; SIGNAL TRANSDUCTION; T LYMPHOCYTE; WILD TYPE;

ANIMALS; ATP-BINDING CASSETTE TRANSPORTERS; FEMALE; GENE EXPRESSION REGULATION; INTERLEUKIN-6; LIVER; LYMPHOCYTES; MALE; MICE; MICE, 129 STRAIN; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; OCTAMER TRANSCRIPTION FACTOR-1; ORGANIC CATION TRANSPORT PROTEINS;

EID: 84884610755     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.113.205369     Document Type: Article

References (62)

1. Augustine LM, Markelewicz RJ, Jr, Boekelheide K, and Cherrington NJ (2005) Xenobiotic and endobiotic transporter mRNA expression in the blood-testis barrier. Drug Metab Dispos 33:182-189.
2. Beuers U, Bilzer M, Chittattu A, Kullak-Ublick GA, Keppler D, Paumgartner G, and Dombrowski F (2001) Tauroursodeoxycholic acid inserts the apical conjugate export pump, Mrp2, into canalicular membranes and stimulates organic anion secretion by protein kinase C-dependent mechanisms in cholestatic rat liver. Hepatology 33:1206-1216.
3. Buist SC and Klaassen CD (2004) Rat and mouse differences in gender-predominant expression of organic anion transporter (Oat1-3; Slc22a6-8) mRNA levels. Drug Metab Dispos 32:620-625.
4. Camporeale A and Poli V (2012) IL-6, IL-17 and STAT3: a holy trinity in autoimmunity? Front Biosci (Landmark Ed) 17:2306-2326.
5. Caramalho I, Lopes-Carvalho T, Ostler D, Zelenay S, Haury M, and Demengeot J (2003) Regulatory T cells selectively express toll-like receptors and are activated by lipopolysaccharide. J Exp Med 197:403-411.
6. Chandra P and Brouwer KL (2004) The complexities of hepatic drug transport: current knowledge and emerging concepts. Pharmaceutical Res 21:719-735.
7. Cheng X, Buckley D, and Klaassen CD (2007) Regulation of hepatic bile acid transporters Ntcp and Bsep expression. Biochem Pharmacol 74:1665-1676.
8. Cherrington NJ, Slitt AL, Li N, and Klaassen CD (2004) Lipopolysaccharidemediated regulation of hepatic transporter mRNA levels in rats. Drug Metab Dispos 32:734-741.
9. Clodfelter KH, Holloway MG, Hodor P, Park SH, Ray WJ, and Waxman DJ (2006) Sex-dependent liver gene expression is extensive and largely dependent upon signal transducer and activator of transcription 5b (STAT5b): STAT5b-dependent activation of male genes and repression of female genes revealed by microarray analysis. Mol Endocrinol 20:1333-1351.
10. Clodfelter KH, Miles GD, Wauthier V, Holloway MG, Zhang X, Hodor P, Ray WJ, and Waxman DJ (2007) Role of STAT5a in regulation of sex-specific gene expression in female but not male mouse liver revealed by microarray analysis. Physiol Genomics 31:63-74.
11. Crispe IN (2012) Migration of lymphocytes into hepatic sinusoids. J Hepatol 57: 218-220.
12. Dong Z, Wei H, Sun R, and Tian Z (2007) The roles of innate immune cells in liver injury and regeneration. Cell Mol Immunol 4:241-252.
13. Duwaerts CC and Gregory SH (2011) Targeting the diverse immunological functions expressed by hepatic NKT cells. Expert Opin Ther Targets 15:973-988.
14. Eberl G, Lees R, Smiley ST, Taniguchi M, Grusby MJ, and MacDonald HR (1999) Tissue-specific segregation of CD1d-dependent and CD1d-independent NK T cells. J Immunol 162:6410-6419.
15. Fu ZD, Csanaky IL, and Klaassen CD (2012) Effects of aging on mRNA profiles for drug-metabolizing enzymes and transporters in livers of male and female mice. Drug Metab Dispos 40:1216-1225.
16. Geier A, Fickert P, and Trauner M (2006) Mechanisms of disease: mechanisms and clinical implications of cholestasis in sepsis. Nat Clin Pract Gastroenterol Hepatol 3:574-585.
17. Geissmann F, Cameron TO, Sidobre S, Manlongat N, Kronenberg M, Briskin MJ, Dustin ML, and Littman DR (2005) Intravascular immune surveillance by CXCR61 NKT cells patrolling liver sinusoids. PLoS Biol 3:e113.
18. Giraud C, Manceau S, Declèves X, Goffinet F, Morini JP, Chappuy H, Batteux F, Chouzenoux S, Yousif S, and Scherrmann JM, et al. (2010) Influence of development, HIV infection, and antiretroviral therapies on the gene expression profiles of ABC transporters in human lymphocytes. J Clin Pharmacol 50:226-230.
19. Godfrey DI and Rossjohn J (2011) New ways to turn on NKT cells. J Exp Med 208: 1121-1125.
20. Green RM, Beier D, and Gollan JL (1996) Regulation of hepatocyte bile salt transporters by endotoxin and inflammatory cytokines in rodents. Gastroenterology 111: 193-198.
21. Gururajan M, Jacob J, and Pulendran B (2007) Toll-like receptor expression and responsiveness of distinctmurine splenic and mucosal B-cell subsets. PLoS ONE 2:e863.
22. Halilbasic E, Claudel T, and Trauner M (2013) Bile acid transporters and regulatory nuclear receptors in the liver and beyond. J Hepatol 58:155-168.
23. Hirschfield GM and Heathcote EJ (2009) Cholestasis and cholestatic syndromes. Curr Opin Gastroenterol 25:175-179.
24. Hirschfield GM, Heathcote EJ, and Gershwin ME (2010) Pathogenesis of cholestatic liver disease and therapeutic approaches. Gastroenterology 139:1481-1496.
25. Ishihara K and Hirano T (2002) Molecular basis of the cell specificity of cytokine action. Biochim Biophys Acta 1592:281-296.
26. Hofmann AF (2007) Biliary secretion and excretion in health and disease: current concepts. Annals of Hepatology 6:15-27.
27. Hofmann AF (2009) The enterohepatic circulation of bile acids in mammals: form and functions. Frontiers in Bioscience: A Journal and Virtual Library 14:2584-2598.
28. Katz SC, Ryan K, Ahmed N, Plitas G, Chaudhry UI, Kingham TP, Naheed S, Nguyen C, Somasundar P, and Espat NJ, et al. (2011) Obstructive jaundice expands intrahepatic regulatory T cells, which impair liver T lymphocyte function but modulate liver cholestasis and fibrosis. J Immunol 187:1150-1156.
29. Kim JH, Kim HS, Kim HY, Oh SJ, and Chung DH (2012) Direct engagement of TLR4 in invariant NKT cells regulates immune diseases by differential IL-4 and IFN-g production in mice. PLoS ONE 7:e45348.
30. Kim PK, Chen J, Andrejko KM, and Deutschman CS (2000) Intraabdominal sepsis down-regulates transcription of sodium taurocholate cotransporter and multidrug resistance-associated protein in rats. Shock 14:176-181.
31. Klaassen CD and Aleksunes LM (2010) Xenobiotic, bile acid, and cholesterol transporters: function and regulation. Pharmacol Rev 62:1-96.
32. Klein C, Wüstefeld T, Assmus U, Roskams T, Rose-John S, Müller M, Manns MP, Ernst M, and Trautwein C (2005) The IL-6-gp130-STAT3 pathway in hepatocytes triggers liver protection in T cell-mediated liver injury. J Clin Invest 115:860-869.
33. Kong B, Csanaky IL, Aleksunes LM, Patni M, Chen Q, Ma X, Jaeschke H, Weir S, Broward M, and Klaassen CD, et al. (2012) Gender-specific reduction of hepatic Mrp2 expression by high-fat diet protects female mice from ANIT toxicity. Toxicol Appl Pharmacol 261:189-195.
34. Kubitz R, Wettstein M, Warskulat U, and Häussinger D (1999) Regulation of the multidrug resistance protein 2 in the rat liver by lipopolysaccharide and dexamethasone. Gastroenterology 116:401-410.
35. Kwekel JC, Desai VG, Moland CL, Branham WS, and Fuscoe JC (2010) Age and sex dependent changes in liver gene expression during the life cycle of the rat. BMC Genomics 11:675.
36. Li N, Choudhuri S, Cherrington NJ, and Klaassen CD (2004) Down-regulation of mouse organic anion-transporting polypeptide 4 (Oatp4; Oatp1b2; Slc21a10) mRNA by lipopolysaccharide through the toll-like receptor 4 (TLR4). Drug Metab Dispos 32:1265-1271.
37. Li N and Klaassen CD (2005) Lipopolysaccharide-induced down-regulation of organic anion transporting polypeptide 4 (Oatp4; Slc21a10) is independent of tumor necrosis factor-alpha, Interleukin-1beta, interleukin-6, or inducible nitric oxide synthase. Toxicol Sci 83:197-203.
38. Liao W, Lin JX, and Leonard WJ (2013) Interleukin-2 at the crossroads of effector responses, tolerance, and immunotherapy. Immunity 38:13-25.
39. Lickteig AJ, Slitt AL, Arkan MC, Karin M, and Cherrington NJ (2007) Differential regulation of hepatic transporters in the absence of tumor necrosis factor-alpha, interleukin-1beta, interleukin-6, and nuclear factor-kappaB in two models of cholestasis. Drug Metab Dispos 35:402-409.
40. Lin JX, Li P, Liu D, Jin HT, He J, Ata Ur Rasheed M, Rochman Y, Wang L, Cui K, and Liu C, et al. (2012) Critical Role of STAT5 transcription factor tetramerization for cytokine responses and normal immune function. Immunity 36:586-599.
41. Maher JM, Slitt AL, Cherrington NJ, Cheng X, and Klaassen CD (2005) Tissue distribution and hepatic and renal ontogeny of the multidrug resistance-associated protein (Mrp) family in mice. Drug Metab Dispos 33:947-955.
42. Merritt ME and Donaldson JR (2009) Effect of bile salts on the DNA and membrane integrity of enteric bacteria. J Med Microbiol 58:1533-1541.
43. Meyer-Bahlburg A, Bandaranayake AD, Andrews SF, and Rawlings DJ (2009) Reduced c-myc expression levels limit follicular mature B cell cycling in response to TLR signals. J Immunol 182:4065-4075.
44. Mulder J, Karpen SJ, Tietge UJ, and Kuipers F (2009) Nuclear receptors: mediators and modifiers of inflammation-induced cholestasis. Front Biosci (Landmark Ed) 14:2599-2630.
45. Parker GA and Picut CA (2012) Immune functioning in non lymphoid organs: the liver. Toxicol Pathol 40:237-247.
46. Pone EJ, Zan H, Zhang J, Al-Qahtani A, Xu Z, and Casali P (2010) Toll-like receptors and B-cell receptors synergize to induce immunoglobulin class-switch DNA recombination: relevance to microbial antibody responses. Crit Rev Immunol 30:1-29.
47. Reynolds JM, Martinez GJ, Chung Y, and Dong C (2012) Toll-like receptor 4 signaling in T cells promotes autoimmune inflammation. Proc Natl Acad Sci USA 109:13064-13069.
48. Ricciardi R, Schaffer BK, Shah SA, Quarfordt SH, Banner BF, Wheeler SM, Donohue SE, Meyers WC, and Chari RS (2001) Bosentan, an endothelin antagonist, augments hepatic graft function by reducing graft circulatory impairment following ischemia/reperfusion injury. J Gastrointest Surg 5:322-329.
49. Roeb E, Purucker E, Gartung C, Geier A, Jansen B, Winograd R, and Matern S (2003) Effect of glutathione depletion and hydrophilic bile acids on hepatic acute phase reaction in rats with extrahepatic cholestasis. Scand J Gastroenterol 38: 878-885.
50. Scheller J, Chalaris A, Schmidt-Arras D, and Rose-John S (2011) The pro- and antiinflammatory properties of the cytokine interleukin-6. Biochim Biophys Acta 1813: 878-888.
51. Seder RA, Paul WE, Davis MM, and Fazekas de St Groth B (1992) The presence of interleukin 4 during in vitro priming determines the lymphokine-producing potential of CD41 T cells from T cell receptor transgenic mice. J Exp Med 176: 1091-1098.
52. Shu Y, Brown C, Castro RA, Shi RJ, Lin ET, Owen RP, Sheardown SA, Yue L, Burchard EG, and Brett CM, et al. (2008) Effect of genetic variation in the organic cation transporter 1, OCT1, on metformin pharmacokinetics. Clin Pharmacol Ther 83:273-280.
53. Streetz KL, Wüstefeld T, Klein C, Kallen KJ, Tronche F, Betz UA, Schütz G, Manns MP, Müller W, and Trautwein C (2003) Lack of gp130 expression in hepatocytes promotes liver injury. Gastroenterology 125:532-543.
54. Sun R, Tian Z, Kulkarni S, and Gao B (2004) IL-6 prevents T cell-mediated hepatitis via inhibition of NKT cells in CD41 T cell- and STAT3-dependent manners. J Immunol 172:5648-5655.
55. Sunman JA, Hawke RL, LeCluyse EL, and Kashuba AD (2004) Kupffer cell-mediated IL-2 suppression of CYP3A activity in human hepatocytes. Drug Metab Dispos 32: 359-363.
56. Taub R (2003) Hepatoprotection via the IL-6/Stat3 pathway. J Clin Invest 112: 978-980.
57. Tirona RG and Kim RB (2005) Nuclear receptors and drug disposition gene regulation. J Pharm Sci 94:1169-1186.
58. Tough DF, Sun S, and Sprent J (1997) T cell stimulation in vivo by lipopolysaccharide (LPS). J Exp Med 185:2089-2094.
59. Trauner M and Boyer JL (2003) Bile salt transporters: molecular characterization, function, and regulation. Physiol Rev 83:633-671.
60. van de Ven R, Oerlemans R, van der Heijden JW, Scheffer GL, de Gruijl TD, Jansen G, and Scheper RJ (2009) ABC drug transporters and immunity: novel therapeutic targets in autoimmunity and cancer. J Leukoc Biol 86:1075-1087.
61. Verbrugge SE, Assaraf YG, Dijkmans BA, Scheffer GL, Al M, den Uyl D, Oerlemans R, Chan ET, Kirk CJ, and Peters GJ, et al. (2012) Inactivating PSMB5 mutations and P-glycoprotein (multidrug resistance-associated protein/ATP-binding cassette B1) mediate resistance to proteasome inhibitors: ex vivo efficacy of (immuno)proteasome inhibitors in mononuclear blood cells from patients with rheumatoid arthritis. J Pharmacol Exp Ther 341:174-182.
62. Zhang Y, Laz EV, and Waxman DJ (2012) Dynamic, sex-differential STAT5 and BCL6 binding to sex-biased, growth hormone-regulated genes in adult mouse liver. Mol Cell Biol 32:880-896.